1 / 18

HIV/ Hep C 2013

HIV/ Hep C 2013. Dr Mike Silverman MD, FRCP, FACP Positive Care Clinic, Whitby. Prognosis . 30 MSM year old infected today can expect same lifespan as HIV negative IFF no additional risk factors

lilac
Télécharger la présentation

HIV/ Hep C 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HIV/ Hep C 2013 Dr Mike Silverman MD, FRCP, FACP Positive Care Clinic, Whitby

  2. Prognosis • 30 MSM year old infected today can expect same lifespan as HIV negative IFF no additional risk factors • Previous data regarding survival- loss of 5 years (older drugs not as effective and more side effects) • Smoking- loss of 12 years of life also lower quality of years you have- [more likely to suffer many complications](heart attack, stroke, cancers, emphysema, leg loss, kidney failure etc…) • Champix/ nicotine patches+gum/ wellbutrin • IDU- overdose, infectious complications (more common especially early on Rx and makes it hard to remember to take meds) • So good news- HIV can be controlled- but we need to take care of addictions

  3. Lower Risk of HIV Acquisition With Broader ART Coverage in Rural S. Africa • Hlabisa, South Africa: rural community with 24% adult HIV prevalence • 20,000 pts started on ART since 2004 • 1413 seroconversions observed; HIV incidence estimated according to time-adjusted ART coverage in local community 1.20 Adjusted HR for HIV Acquisition* 1.00 P = .59 0.80 P = .002 0.60 P < .001 P = .016 0.40 0.20 0 < 10 10-20 20-30 30-40 > 40 ART Coverage (% of All HIV+ Pts on ART) *Adjusted for age, sex, community-level HIV prevalence, urban vs rural locale, marital status, > 1 partner in last 12 mos, and household wealth index. Tanser F, et al. CROI 2012. Abstract 136LB.

  4. Transmission • O52- implications • Legal regarding disclosure- if use condom not required (easier for relationship than disclosing later…if relationship is goal) • Pregnancy without IVF? Using PreP?- still need to work with MD, but doable! • PreP- 60% protective using oral tenofovir- great deal of variability based on whether PreP actually taken

  5. When to start on Rx? • CD4<500- Why? • Higher risk of heart disease, kidney disease, liver disease if not on Rx (chronic inflammation) • Drugs are now so much safer and easier to take, even though risk of AIDS illnesses (pneumonia and other infections, cancers) doesn’t start rising until CD4 lower, accelerated aging occurs if not on treatment from inflammation so start earlier • What if CD4>500? • If any heart or kidney or liver disease, (including Hep B or C) or in discordant relationship- should be on Rx • Should everyone be on Rx?- debated- studies to clarify this are ongoing

  6. How about non-progressors? • Very rare (~0.7% of Europeans, 0.3% of African descent) • Some very lucky –undetectable viral load even though never on Rx (elite controllers) • VERY rare, much more common, “slow progressors” • More likely to be a slow progressor if treated when acutely infected • Not commonly recognized (flu like illness+/- rash, or more commonly no symptoms at all) • Attempt to recognize early • Even Elite non-progressors likely should be treated in some cases to prevent premature aging

  7. PEOPLE Starting ART at Higher CD4+ Cell Counts Overall, but Disparities Remain • CD4+ cell count at start of ART (cells/mm3), 2009[1] • In San Francisco study, overall trends of starting ART at higher CD4+ counts, but pts initiating ART at CD4+ counts > 350 cells/mm3 significantly more likely to be white, older, MSM, nonpoor, and diagnosed by private provider[2] 246 262 307 252 118 137 234 140 185 145-176 89 Low income 200 225 Middle income 286 150 High income 1. Mugglin C, et al. CROI 2012. Abstract 100. 2. Truong HH, et al. CROI 2012. Abstract 139.

  8. Still having a problem that HIV is diagnosed late especially in smaller communities in Canada • More advanced disease • Harder to get viral load down • Often present with serious and sometimes life threatening problems

  9. Lots of New Meds • Now 3 Single tablet formulations to choose from and all covered-ODB • Atripla- Tenofovir+FTC+Efavirenz • Complera- Tenofovir+FTC+ Rilpivirine • Stribild- Tenofovir+FTC+cobicistat+elvitagrivir • Issues- Food, antacids, drug interactions, blood monitoring, timing of treatment • Vs nightmares, anxiety, high cholesterol • New one –Abacavir/3TC/dolutegravir on the way

  10. Older choices (multiple tablets) still very good • Raltegravir (Isentress) - twice daily but very durable response and almost no side effects • Ritonavir (norvir) boosted- atazanavir (Reyataz)/darunavir (prezista)- once daily • ritonavir/lopinavir (kaletra)- twice daily so less often used • Nevirapine (now once daily), Intelence (2tabs once daily) • Kivexa- now can predict allergy with genetic testing- concerns about heart disease seem to be waning • Maraviroc- good drug- twice daily- not easy to get coverage • AZT- rarely used except in pregnancy, and newborns • Old drugs (ddI, d4T etc..) replaced by much better options • No longer lipodystrophy, atrophy

  11. Lots of choices • No one right answer • Need to discuss side effects and lifestyle with doctor to see what works best for you

  12. Drug hollidays • Like any vacation these can be very “expensive” • Irreversible drug resistance can occur- if restart meds may not work and all meds in same family also will not work • When our medications were toxic these had some rationale • We now know much more likely to die or have serious complications such as heart attack, stroke, kidney or liver problem if use a drug holliday

  13. What about short holidays- ie missing occassionaly? • Missing >10% of pills dramatically increases risk of irreversible drug resistance • Safest approach is keep a routine so never miss • Keep extra tablets with you in case sleep over somewhere • Take at same time so becomes a habit • If uncertain about ? Side effect- contact clinic as can switch to something new. MUCH safer than stopping for a bit then starting something else • Note: if holidays occur- and then resistance- usually can’t use one tablet, once daily regimens anymore

  14. HIV Vaccine • Some promising developments but none ready for prime time yet • If already positive -Need to keep undetectable viral load so that may be able to be on vaccine when available then “stop meds” • New drugs to “get rid of viral reservoir” in development- work better the longer you have been undetectable

  15. What if I can’t get to undetectable? • Make sure not forgetting more than you think? • Recheck all medications? Drug interactions- smoking cigarettes/marijuana? • Check blood levels- sometimes if very large person or fast metabolism need a larger dose • Sometimes 3 drugs are not enough and need a fourth • (now that much less toxic this isn’t so bad)

  16. Cure? • Berlin patient- now 2 Americans – bone marrow transplant • 30% 1 year death rate so only done if another reason- leukemia/lymphoma • Worked even in non-CCR5 negative bone marrow donor • Recent Baby- very early treatment x 18 months then stopped

  17. Overlapping HCV & HIV Epidemics HIV HCV 40 million 170 million 10 million

More Related